Search results
Cucumber recall update as FDA sets highest risk level
Newsweek· 2 days agoA range of recalled whole cucumbers have been designated a Class I risk level by the U.S. Food and...
Coronavirus company news summary – US FDA authorises LetsGetChecked’s home collection Covid-19 test...
Medical Device Network via Yahoo Finance· 3 hours agoFDA Authorization of Let’sGetChecked’s Home Collection COVID-19 Test LetsGetChecked has announced that the US Food and Drug Administration (FDA ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 16 hours agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
US FDA approves Merck's pneumococcal vaccine for adults
Reuters· 10 hours ago, opens new tab said on Monday the U.S. Food and Drug Administration has approved its...
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe trial assessed the drug's efficacy in adults with NTRK-positive solid tumours, demonstrating...
What Does FDA's Draft Platform Guidance Mean For CGT Companies?
BioresearchOnline· 1 day agoThe U.S. FDA released the much-anticipated draft guidance Platform Technology Designation Program...
FDA took 15 months to act on infant formula whistleblower complaint, audit says
The Hill via Yahoo News· 11 hours agoThe Food and Drug Administration (FDA) was dangerously slow to respond to multiple complaints about...
AstraZeneca/Fibrogen’s Roxadustat FDA Review Further Delayed Following Unanticipated Advisory...
Clinical Trials Arena via Yahoo Finance· 1 day agoFDA Delays Decision on AstraZeneca/Fibrogen’s Roxadustat for CKD Anemia On March 1, AstraZeneca and...
Milestone for Biotest: US Approval for Innovative Immunoglobulin Yimmugo
NewMediaWire via Yahoo Finance· 13 hours agoFDA approval secures significant future sales and earnings growth through entry into the world's...
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 18 hours agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...